Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Thromb Res. 2014 Sep 6;134(5):1123–1129. doi: 10.1016/j.thromres.2014.08.024

Table 1.

Effects of CDSO3 on the Michaelis–Menten Parameters of Thrombin and Various Substratesa

[CDS03] (nM) Substrate Km (μM)b Vmax (mAU/min)b
0 Spectrozyme TH 2.2 ± 0.2 21 ± 0.7
30 1.3 ± 0.1 15 ± 0.3
105 1.2 ± 0.1 11 ± 0.3
300 0.85 ± 0.1 9.5 ± 0.2
0 S-2238 1.3 ± 0.1 10.4 ± 0.2
1 1.3 ± 0.2 8.8 ± 0.2
10.5 1.1 ± 0.2 6.2 ± 0.2
30 1.4 ± 0.3 5.0 ± 0.2
105 1.2 ± 0.3 4.6 ± 0.2
0 Spectrozyme FXa 61 ± 3 36 ± 0.6
10.5 42 ± 4 31 ± 0.8
30 40 ± 5 23 ± 0.9
105 40 ± 5 18 ± 0.7
203 39 ± 10 12 ± 1
0 Spectrozyme Pro 1.3 ± 0.2 36 ± 1
30 0.5 ± 0.05 23 ± 0.3
120 0.7 ± 0.1 21 ± 0.5
0 Spectrozyme PCa 4.5 ± 0.5 107 ± 3
30 7.3 ± 2.0 82 ± 4
90 9.1 ± 3.2 67 ± 5
a

KM and VMAX values of substrate hydrolysis by human thrombin were measured as described in Experimental Procedures. mAU indicates milliabsorbance units.

b

Error represents ±1 SE.